Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George M Bright

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of the Endocrine Society|May 13, 2021
Development of a Predictive Enrichment Marker for the Oral GH Secretagogue LUM-201 in Pediatric Growth Hormone DeficiencyGeorge M Bright, Minh-Ha T Do, John C McKew, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2007
Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled studyPinchas Cohen, Alan D Rogol, Campbell P Howard, et al.
The Journal of Clinical Endocrinology and Metabolism|November 28, 2024
The Role of the GH/IGF Axis in Statural Growth and Harmonious Body Proportionality: In Search of Vitruvian ManJaime Guevara-Aguirre, George M Bright, Alexandra Guevara, et al.
Journal of the Endocrine Society|May 13, 2021
Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHDWerner F Blum, George M Bright, Minh-Ha T Do, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2015
A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone DeficiencyWayne V Moore, Huong Jil Nguyen, Gad B Kletter, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2013
A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adultsKevin C J Yuen, Gerard S Conway, Vera Popovic, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of the Endocrine Society|May 13, 2021
Development of a Predictive Enrichment Marker for the Oral GH Secretagogue LUM-201 in Pediatric Growth Hormone DeficiencyGeorge M Bright, Minh-Ha T Do, John C McKew, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2007
Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled studyPinchas Cohen, Alan D Rogol, Campbell P Howard, et al.
The Journal of Clinical Endocrinology and Metabolism|November 28, 2024
The Role of the GH/IGF Axis in Statural Growth and Harmonious Body Proportionality: In Search of Vitruvian ManJaime Guevara-Aguirre, George M Bright, Alexandra Guevara, et al.
Journal of the Endocrine Society|May 13, 2021
Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHDWerner F Blum, George M Bright, Minh-Ha T Do, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2015
A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone DeficiencyWayne V Moore, Huong Jil Nguyen, Gad B Kletter, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2013
A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adultsKevin C J Yuen, Gerard S Conway, Vera Popovic, et al.
Pageof 2